We’re delighted to announce that we’ve won an Irish Healthcare Award for groundbreaking research on the first Irish data demonstrating the impact of HPV vaccination on cervical cancer.
The award-winning research paper was a collaboration involving the HSE’s National Screening Service and National Immunisation Office (NIO); the School of Public Health, Physiotherapy & Sports Science, University College Dublin; and the School of Public Medicine, Trinity College Dublin.
Lead author and CervicalCheck data analyst Micheál Rourke said: “Winning this award is a proud moment for the research team and a testament to our collective efforts in collaboration. It’s the first data in Ireland combining CervicalCheck data with NIO data and offers early insights into the potential impact of combined HPV vaccination and cervical screening in reducing cervical disease.”
Our Chief Executive Fiona Murphy applauded the achievement, saying: “This recognition underscores the exceptional dedication and expertise of our research team. It’s an example of how research can drive progress, supporting the World Health Organization’s global strategy to eliminate cervical cancer. This study not only strengthens international evidence - it also brings us one step closer to a future where cervical cancer is rare.”
‘The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland’ is published in the Irish Journal of Medical Science.
The 2024 Irish Healthcare Awards took place in the Dublin Royal Convention Centre on Wednesday 4 December.